Literature DB >> 10599476

Neural circuits mediating stress.

J F López1, H Akil, S J Watson.   

Abstract

Stress has been linked to the pathophysiology and pathogenesis of mood and anxiety disorders. Over the past few years, our understanding of the brain and neuroendocrine circuits that are linked to the stress response have increased dramatically. This article reviews a series of animal and human studies aimed at understanding what are the pathways by which stress is perceived, processed, and transduced into a neuroendocrine response. We focus on the classic stress circuit: the limbic-hypothalamic-pituitary-adrenal (LHPA) axis. These studies indicate that the LHPA stress circuit is a complex system with multiple control mechanisms and that these mechanisms are altered in pathological states, such as chronic stress and depression. These studies also suggest that the interactions between the LHPA and other neurotransmitters, such as serotonin, may provide the neurobiological substrate by which stress may affect mood.

Entities:  

Mesh:

Year:  1999        PMID: 10599476     DOI: 10.1016/s0006-3223(99)00266-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  60 in total

Review 1.  Depression, antidepressants, and neurogenesis: a critical reappraisal.

Authors:  Nicola D Hanson; Michael J Owens; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Sleep disorders in psychiatric practice.

Authors:  Waldemar Szelenberger; Constantin Soldatos
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

3.  Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.

Authors:  Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 4.  Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury.

Authors:  Mark A Prendergast; Patrick J Mulholland
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

5.  Investigating emotion with music: an fMRI study.

Authors:  Stefan Koelsch; Thomas Fritz; D Yves V Cramon; Karsten Müller; Angela D Friederici
Journal:  Hum Brain Mapp       Date:  2006-03       Impact factor: 5.038

6.  Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray.

Authors:  Roger A Kroes; Jeffrey Burgdorf; Nigel J Otto; Jaak Panksepp; Joseph R Moskal
Journal:  Behav Brain Res       Date:  2007-03-25       Impact factor: 3.332

7.  Subcortical gray matter volume abnormalities in healthy bipolar offspring: potential neuroanatomical risk marker for bipolar disorder?

Authors:  Cecile D Ladouceur; Jorge R C Almeida; Boris Birmaher; David A Axelson; Sharon Nau; Catherine Kalas; Kelly Monk; David J Kupfer; Mary L Phillips
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-05       Impact factor: 8.829

8.  Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder.

Authors:  Yarema B Bezchlibnyk; Xiujun Sun; Jun-Feng Wang; Glenda M MacQueen; Bruce S McEwen; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

9.  Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.

Authors:  Doug Hyun Han; Sun Mi Kim; Jung Eun Choi; Kyung Joon Min; Perry F Renshaw
Journal:  J Psychopharmacol       Date:  2013-01-16       Impact factor: 4.153

10.  Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.

Authors:  Cecilea C Clayton; Michael R Bruchas; Michael L Lee; Charles Chavkin
Journal:  Mol Pharmacol       Date:  2009-12-03       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.